Ascites in Ovarian Cancer
Birth control pills may lower your risk for ovarian cancer
BRCA1 and BRCA2 testing for Ovarian Cancer
Chemoresistance in ovarian and primary peritoneal cancer
Chemotherapy After Debulking Surgery
Clear Cell Ovarian Cancer Prognosis
Clinical Trials for Ovarian Cancer
Consolidation Therapy for Ovarian Cancer
Consolidation therapy for ovarian cancer
Does arthritis elevate CA-125
Doxil and Leg Pain
Elevated CA125 after ovarian cancer treatment
Elevated CA125 Level and Tamoxifen
Family history of ovarian cancer
Fertility drugs and borderline ovarian cancers
Follow up care after treatment for Borderline Mucinous Ovarian Tumor
Follow Up for Primary Peritoneal Cancer
Follow Up With no CA125 Elevation
Gemcitabine for the treatment of ovarian cancer
Genetic link for Ovarian Cancer
Terapia Hormonal Después del cáncer ovárico
Malignant granulosa cell tumor
Malignant Mixed Mullerian Tumor (MMMT) of the Ovary
Monoclonal Antibodies for Ovarian Cancer
Normal CA-125 with Recurrence
Occurrence and Recommended Treatment of Lymphedema
OncoGel and Ovarian Cancer
Oopherectomy
Ovarian cancer detection
Ovarian Cancer Recurrence
Ovarian Cancer Surveillance
Ovarian cancers of low malignant potential
Ovarian Mass
Ovarian Tumor With Low Malignant Potential
PET/CT for Ovarian Cancer
Possibility of ovarian cancer after removal of the ovaries
Premarin cream and the risk for ovarian cancer
Preventing ovarian cancer
Primary peritoneal cancer
Secretions and Oral Care
Standard Treatment for Advanced Ovarian Cancer
Successful pregnancy after ovarian cancer
Symptoms of endometriosis and ovarian cancer
Symptoms of Ovarian Cancer
Testing for Ovarian Cancer
The most commonly used chemotherapy treatment for ovarian cancer
Tratamiento para el cáncer recurrente ovárico en etapa III C
Treatment of borderline cancers of the ovary
Treatment of Low Malignant Potential (LMP) Ovarian Tumors
Treatment options for recurrent ovarian cancer
Vaccines for Ovarian Cancer
What is CA125
English
News
Ovarian Cancer DNA Detected in Vaginal Fluid

Oct 9, 2014 - Researchers have found it's possible to detect ovarian cancer gene mutations in vaginal fluid samples -- a finding they hope is a step toward an effective screening test for the disease. The findings were published online Oct. 6 in Obstetrics & Gynecology.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información